Old Web
English
Sign In
Acemap
>
authorDetail
>
Susan C. Charman
Susan C. Charman
Cystic Fibrosis Trust
Medicine
Cystic fibrosis
Internal medicine
Intensive care medicine
Ivacaftor
4
Papers
102
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry.
2020
Journal of Cystic Fibrosis
Sigal Kaplan
Andrew Lee
Noreen Caine
Susan C. Charman
Diana Bilton
Show All
Source
Cite
Save
Citations (1)
Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trial.
2020
BMJ Open Respiratory Research
Gemma Stanford
Jane C. Davies
Omar S. Usmani
Winston Banya
Susan C. Charman
Mandy Jones
Nicholas J. Simmonds
Diana Bilton
Show All
Source
Cite
Save
Citations (2)
Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens: A Cohort Study Using National Registry Data
2019
Annals of the American Thoracic Society
Freddy Frost
Dilip Nazareth
Susan C. Charman
Craig Winstanley
Martin J. Walshaw
Show All
Source
Cite
Save
Citations (29)
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries
2019
Journal of Cystic Fibrosis
N. Volkova
Kristin Moy
Jennifer Evans
Daniel Campbell
S. Tian
Christopher Simard
M. Higgins
Michael W. Konstan
Gregory S. Sawicki
Alexander Elbert
Susan C. Charman
Bruce C. Marshall
Diana Bilton
Show All
Source
Cite
Save
Citations (70)
1